Fluticasone Furoate

Featured Article

Drugmaker GlaxoSmithKline has applied for both U.S. Food and Drug Administration and European approval for its new allergy medicine, Allermist. Allermist (fluticasone furoate) has shown success in clinical trials in treating the symptoms of seasonal allergic rhinitis and perennial allergic rhinitis in both children and adults.

Read more

More information on "Fluticasone Furoate"

From Our Experts

See more SharePosts »

From Our Sources

More on Allergy »